TFF PHARMACEUTICALS, INC.: basic earnings per share
Basic earnings per share for TFF PHARMACEUTICALS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All TFF PHARMACEUTICALS, INC. financial histories
What this measure means
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
Exact concept: us-gaap:EarningsPerShareBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Reading these values
This selected numerical history matches Diluted earnings per share for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-01-01 | 2023-12-31 | -11.85 | USD/shares | 2024-03-28 | 10-K · 0001213900-24-027185 |
| 2022-01-01 | 2022-12-31 | -26.49 | USD/shares | 2024-03-28 | 10-K · 0001213900-24-027185 |
| 2021-01-01 | 2021-12-31 | -1.25 | USD/shares | 2023-03-31 | 10-K · 0001213900-23-025454 |
Related financial histories
- TFF PHARMACEUTICALS, INC.: total assets
- TFF PHARMACEUTICALS, INC.: total liabilities
- TFF PHARMACEUTICALS, INC.: stockholders equity
- TFF PHARMACEUTICALS, INC.: cash and cash equivalents
- TFF PHARMACEUTICALS, INC.: net income or loss
- TFF PHARMACEUTICALS, INC.: operating cash flow
- TFF PHARMACEUTICALS, INC.: capital expenditure payments
- TFF PHARMACEUTICALS, INC.: revenue
- TFF PHARMACEUTICALS, INC.: financing cash flow
- TFF PHARMACEUTICALS, INC.: investing cash flow
- TFF PHARMACEUTICALS, INC.: retained earnings or deficit
- TFF PHARMACEUTICALS, INC.: basic weighted-average shares
- TFF PHARMACEUTICALS, INC.: diluted weighted-average shares
- TFF PHARMACEUTICALS, INC.: diluted earnings per share
- TFF PHARMACEUTICALS, INC.: net property, plant and equipment
- TFF PHARMACEUTICALS, INC.: share-based compensation expense
- TFF PHARMACEUTICALS, INC.: operating income or loss
- TFF PHARMACEUTICALS, INC.: current assets
- TFF PHARMACEUTICALS, INC.: current liabilities
- TFF PHARMACEUTICALS, INC.: current accounts payable
- TFF PHARMACEUTICALS, INC.: operating expenses
- TFF PHARMACEUTICALS, INC.: research and development expense
Inspect the source
- Entity
- TFF PHARMACEUTICALS, INC. / CIK 0001733413
- Captured
- 2026-09-21T17:25:24.015Z
- SEC response SHA-256
831f4629fefc666a0d697443131c6e51c7c7a82a58f012a492b81a69560d76f0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001733413.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))